CC
Casdin Capital Portfolio holdings
AUM
$1.1B
1-Year Return
24.98%
This Quarter Return
+11.22%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$1.1B
AUM Growth
-$126M
(-10%)
Cap. Flow
-$163M
Cap. Flow
% of AUM
-14.81%
Top 10 Holdings %
Top 10 Hldgs %
85.29%
Holding
45
New
1
Increased
9
Reduced
12
Closed
12
Top Buys
| 1 |
Structure Therapeutics
GPCR
|
+$10.9M |
| 2 |
Relay Therapeutics
RLAY
|
+$7.96M |
| 3 |
Eli Lilly
LLY
|
+$6.63M |
| 4 |
Illumina
ILMN
|
+$4.77M |
| 5 |
Prime Medicine
PRME
|
+$2.96M |
Top Sells
| 1 |
Revolution Medicines
RVMD
|
+$29.8M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
+$28.9M |
| 3 |
BioLife Solutions
BLFS
|
+$21.5M |
| 4 |
Exact Sciences
EXAS
|
+$16.7M |
| 5 |
Intellia Therapeutics
NTLA
|
+$14.2M |
Sector Composition
| 1 | Healthcare | 98.96% |
| 2 | Consumer Staples | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Absci
ABSI
$410M
| $2.5M | 0.23% |
973,260
| – | – |
|
27
Pacific Biosciences
PACB
$378M
| $897K | 0.08% |
723,767
| – | – |
|
28
Recursion Pharmaceuticals
RXRX
$2.12B
| $837K | 0.08% |
165,323
| – | – |
|
29
Century Therapeutics
IPSC
$44.8M
| $686K | 0.06% |
1,228,190
-1,984,126
| -62% | -$1.11M |
|
|
CTNM
30
Contineum Therapeutics
CTNM
$331M
| $589K | 0.05% |
148,333
| – | – |
|
31
Ginkgo Bioworks
DNA
$618M
| $411K | 0.04% |
36,493
| – | – |
|
32
Monte Rosa Therapeutics
GLUE
$302M
| $388K | 0.04% |
86,014
| – | – |
|
33
Tenaya Therapeutics
TNYA
$209M
| $221K | 0.02% |
361,969
-6,371,002
| -95% | -$3.89M |
|
34
Dyne Therapeutics
DYN
$1.88B
| – | – |
-100,000
| Closed | -$1.05M |
|
35
GE HealthCare
GEHC
$35.6B
| – | – |
-100,000
| Closed | -$8.07M |
|
|
BPMC
36
DELISTED
Blueprint Medicines
BPMC
| – | – |
-326,378
| Closed | -$28.9M |
|
|
KRON
37
DELISTED
Kronos Bio
KRON
| – | – |
-123,839
| Closed | -$102K |
|
38
Moderna
MRNA
$9.88B
| – | – |
-225,000
| Closed | -$6.38M |
|
|
39
Intellia Therapeutics
NTLA
$1.23B
| – | – |
-2,000,000
| Closed | -$14.2M |
|
40
Solid Biosciences
SLDB
$413M
| – | – |
-775,000
| Closed | -$2.87M |
|
41
Teladoc Health
TDOC
$1.37B
| – | – |
-300,000
| Closed | -$2.39M |
|
42
Tango Therapeutics
TNGX
$761M
| – | – |
-125,000
| Closed | -$171K |
|
|
TSVT
43
DELISTED
2seventy bio
TSVT
| – | – |
-2,000,000
| Closed | -$9.88M |
|
44
Verastem
VSTM
$575M
| – | – |
-600,000
| Closed | -$3.62M |
|
|
ONC
45
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.9B
| – | – |
-40,000
| Closed | -$10.9M |
|